XML 37 R23.htm IDEA: XBRL DOCUMENT v3.22.2.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Details) - obligation
9 Months Ended
Sep. 30, 2022
Jul. 31, 2022
Mar. 31, 2021
Sep. 30, 2019
New Accounting Pronouncements or Change in Accounting Principle [Line Items]        
Expected dividend rate 0.00%      
Minimum        
New Accounting Pronouncements or Change in Accounting Principle [Line Items]        
Useful life 3 years      
Maximum        
New Accounting Pronouncements or Change in Accounting Principle [Line Items]        
Useful life 7 years      
Mundipharma Medical Company        
New Accounting Pronouncements or Change in Accounting Principle [Line Items]        
Number of performance obligations       3
Janssen Pharmaceuticals, Inc.        
New Accounting Pronouncements or Change in Accounting Principle [Line Items]        
Number of performance obligations     1  
Janssen Pharmaceuticals, Inc. | Janssen Collaboration Agreement        
New Accounting Pronouncements or Change in Accounting Principle [Line Items]        
Number of performance obligations     3  
Melinta Therapeutics, Inc.        
New Accounting Pronouncements or Change in Accounting Principle [Line Items]        
Number of performance obligations   3